Cas:2696-92-6 Nitrosyl chloride manufacturer & supplier

We serve Chemical Name:Nitrosyl chloride CAS:2696-92-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Nitrosyl chloride

Chemical Name:Nitrosyl chloride
CAS.NO:2696-92-6
Synonyms:EINECS 220-273-1;Tildens Reagent;chloroketoamine;nitrosylchloride;glyoxyl chloride;Nitrogen oxychloride;nirosyl chloride;nitroso-chloride;Nitrosonium chloride
Molecular Formula:ClNO
Molecular Weight:65.45910
HS Code:

Physical and Chemical Properties:
Melting point:-64.5ºC
Boiling point:-5
Density:1.417
Index of Refraction:1.432
PSA:29.43000
Exact Mass:64.96680
LogP:0.90660

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:1069
Packing Group:


Contact us for information like EINECS 220-273-1 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Nitrosonium chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,chloroketoamine Use and application,nirosyl chloride technical grade,usp/ep/jp grade.


Related News: Roche’s second anti-tau antibody UCB0107, partnered with UCB, is also slated to enter deeper testing this year. Tau had appeared to have fresh promise as a rival of sorts to amyloid. Tau theory goes that neurofibrillary tangles that form inside cells clog up the brain, and clearing this can help Alzheimer’s patients. Nitrosyl chloride manufacturer Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment. Nitrosyl chloride supplier Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment. Nitrosyl chloride vendor Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment. Nitrosyl chloride factory First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.